Toggle navigation
Drugs
Combinations
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Esomeprazole (Esomeprazole)
Indications and Reactions:
Role
Indications
Reactions
Secondary
Drug Use For Unknown Indication
28.1%
Product Used For Unknown Indication
14.1%
Barrett's Oesophagus
7.8%
Ill-defined Disorder
6.3%
Gastrooesophageal Reflux Disease
4.7%
Helicobacter Infection
4.7%
Anaesthesia
3.1%
Drug Abuse
3.1%
Gastritis
3.1%
Hypertension
3.1%
Knee Arthroplasty
3.1%
Musculoskeletal Disorder
3.1%
Prophylaxis Against Gastrointestinal Ulcer
3.1%
Vertebral Artery Stenosis
3.1%
Affective Disorder
1.6%
Depression
1.6%
Diabetes Mellitus
1.6%
Dyskinesia
1.6%
Hypothyroidism
1.6%
Oesophagitis
1.6%
White Blood Cell Count Increased
9.5%
Abdominal Pain Upper
4.8%
Anaemia
4.8%
Asthenia
4.8%
Blood Potassium Decreased
4.8%
Diabetes Mellitus
4.8%
General Physical Health Deterioration
4.8%
Hypotension
4.8%
Inappropriate Antidiuretic Hormone Secretion
4.8%
Nausea
4.8%
No Therapeutic Response
4.8%
Non-small Cell Lung Cancer
4.8%
Pleural Effusion
4.8%
Pneumothorax
4.8%
Sudden Death
4.8%
Swollen Tongue
4.8%
Syncope
4.8%
Tetany
4.8%
Toxic Epidermal Necrolysis
4.8%
Toxic Skin Eruption
4.8%
Concomitant
Multiple Myeloma
18.1%
Product Used For Unknown Indication
11.6%
Ill-defined Disorder
9.8%
Liver Transplant
7.4%
Myocardial Ischaemia
5.6%
Non-small Cell Lung Cancer
5.1%
Osteoporosis
5.1%
Myelodysplastic Syndrome
4.2%
Renal Cell Carcinoma Stage Unspecified
3.7%
Actinic Keratosis
3.3%
Acute Myeloid Leukaemia
3.3%
Pulmonary Hypertension
3.3%
Depression
2.8%
Liver Transplant Rejection
2.8%
Pancreatic Carcinoma Metastatic
2.8%
Prophylaxis Against Transplant Rejection
2.8%
Drug Use For Unknown Indication
2.3%
Smoking Cessation Therapy
2.3%
Cardiovascular Disorder
1.9%
Essential Hypertension
1.9%
Ventricular Tachycardia
10.2%
Vomiting
9.1%
Weight Decreased
9.1%
Rhabdomyolysis
6.8%
Thrombocytopenia
6.8%
Pyrexia
5.7%
Oedema Peripheral
4.5%
Pneumonia
4.5%
Renal Failure Acute
4.5%
Tachycardia
4.5%
Biliary Anastomosis Complication
3.4%
Hepatitis
3.4%
Infection
3.4%
Peak Expiratory Flow Rate Decreased
3.4%
Pulmonary Oedema
3.4%
Renal Failure
3.4%
Right Ventricular Failure
3.4%
Sepsis
3.4%
Septic Shock
3.4%
Skin Ulcer
3.4%
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Drug Data
Drugs
Combinations